Are Paclitaxel-Eluting Stents Better in Unprotected Left Main Coronary Artery Disease? Three-Year Clinical and Intravascular Imaging Results From a Randomized Study

Abstract

Background and Objective. Recent publications have demonstrated superior outcomes in unprotected left main patients after paclitaxel-eluting stent (PES) implantation. Long-term data in these patients are limited. The aim of this study was to evaluate if intravascular ultrasound (IVUS)-guided PES implantation is superior to bare metal stent (BMS) implantation in unprotected left main disease after lesion pretreatment with cutting balloon during long-term follow-up. Material and Methods. Unprotected left main patients were randomized to BMS (n=50) or PES implantation (n=53). All interventions were IVUS-guided and cutting balloon pretreatment before stenting was performed in all patients. All patients were scheduled for 6-month and 3-year follow-up. Subgroups of patients who underwend IVUS and OCT imaging at 3-year follow-up were analyzed. The primary endpoint was the major adverse cardiac events (MACEs) defined as death, Q-wave myocardial infarction, or target lesion revascularization. Results. Baseline characteristics were similar in both the groups with a mean SYNTAX score of 31.4±14.5 in BMS and 32.6±11.7 in PES patients (P=0.718). At 3 years, MACEs occurred in 18 patients (36.0%) in the BMS and 7 patients (13.2%) in the PES group (P=0.011). By IVUS, percent neointimal volume obstruction at 3 years was reduced from 18.1%±8.7% with BMSs to 10.0%±5.4% with PESs (P<0.001). The total number of uncovered stent struts per OCT image and IVUS image was 0.4±0.8 and 1.2±1.5, respectively (P<0.001). Conclusions. The current study demonstrated that IVUS-guided PES implantation was superior to BMS implantation after cutting balloon pretreatment in unprotected left main disease at 3 years. If compared with IVUS, OCT was more precise in the assessment of stent endothelization.

Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium

“…Among patients randomized to a planned two-stent strategy in the EBC Main, plaque pretreatment with cutting balloon, rotablation, or lithotripsy was undertaken in 22% of main vessels and 15% of side branches. The lower mortality rate in the present study may be in part related to our learning curve gained from the first randomized trial (2004–2006) comparing DES and bare-metal stent for left main intervention, which showed a 2% death rate at 6 months and 7% at 3 years [ 8 , 18 ].…”

Usage of different vessel models in a flow-through cell: in vitro study of a novel coated balloon catheter

“…3 The cytotoxic, anti-proliferative effect of DES on the vessel wall has been widely explored. 2,4 Preclinical studies with DCB have shown that 3 mg mm À2 paclitaxel is the effective dose to achieve an efficient, long-term, antiproliferative effect on the vessel wall. 2,5 Drug delivery during angioplasty depends on drug dose, transfer system, dilation time, release pattern and appropriate balloon coating.…”